These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18650408)

  • 1. Hepatitis C is less aggressive in hemodialysis patients than in nonuremic patients.
    Trevizoli JE; de Paula Menezes R; Ribeiro Velasco LF; Amorim R; de Carvalho MB; Mendes LS; Neto CJ; de Deus Macedo JR; de Assis F; Neves R
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1385-90. PubMed ID: 18650408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation.
    Sterling RK; Sanyal AJ; Luketic VA; Stravitz RT; King AL; Post AB; Mills AS; Contos MJ; Shiffman ML
    Am J Gastroenterol; 1999 Dec; 94(12):3576-82. PubMed ID: 10606322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hemodialysis therapy on hepatitis C virus infection: a deeper insight.
    Fabrizi F; Messa P; Martin P
    Int J Artif Organs; 2009 Jan; 32(1):1-11. PubMed ID: 19241358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection.
    Furusyo N; Hayashi J; Ariyama I; Sawayama Y; Etoh Y; Shigematsu M; Kashiwagi S
    Am J Gastroenterol; 2000 Feb; 95(2):490-6. PubMed ID: 10685756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the progression of hepatic fibrosis in end-stage kidney disease patients with hepatitis C virus infection.
    Becker VR; Badiani RG; Lemos LB; Perez RM; Medina-Pestana JO; Lanzoni VP; Ferreira AP; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1395-9. PubMed ID: 19525852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fibrosis progression in HIV/hepatitis C virus coinfected patients with normal aminotransferases levels.
    Pace FH; Ferreira LE; Silva AE; Ferraz ML
    Rev Soc Bras Med Trop; 2012; 45(4):444-7. PubMed ID: 22930041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult hepatitis B virus infection in hemodialysis patients with chronic HCV infection.
    Siagris D; Christofidou M; Triga K; Pagoni N; Theocharis GJ; Goumenos D; Lekkou A; Thomopoulos K; Tsamandas AC; Vlachojannis J; Labropoulou-Karatza C
    J Nephrol; 2006; 19(3):327-33. PubMed ID: 16874693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis prevents liver disease caused by hepatitis C virus: role of hepatocyte growth factor.
    Rampino T; Arbustini E; Gregorini M; Guallini P; Libetta C; Maggio M; Ranghino A; Silini E; Soccio G; Dal Canton A
    Kidney Int; 1999 Dec; 56(6):2286-91. PubMed ID: 10594807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C in chronic kidney disease: predialysis patients present more severe histological liver injury than hemodialysis patients?
    Lemos LB; Perez RM; Lemos MM; Lanzoni VP; Draibe SA; Silva IS; Silva AE; Ferraz ML
    Am J Nephrol; 2007; 27(2):191-6. PubMed ID: 17356254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of hepatitis B and hepatitis C virus-infected renal allograft recipients with liver biopsy and noninvasive parameters.
    Fehr T; Riehle HM; Nigg L; Grüter E; Ammann P; Renner EL; Ambühl PM
    Am J Kidney Dis; 2003 Jul; 42(1):193-201. PubMed ID: 12830472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
    Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury.
    El Aggan H; Farahat N; El Deeb N; Zeid A; El-Shendidi A
    Microb Pathog; 2019 Jun; 131():65-74. PubMed ID: 30926417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological features of chronic hepatitis C in haemodialysis patients.
    Sakellariou S; Boletis JN; Sypsa V; Psichogiou M; Tiniakos D; Delladetsima I
    Liver Int; 2014 Jul; 34(6):e56-61. PubMed ID: 25234282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Hsu SJ; Chen CL; Hwang JJ; Lai MY; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2010 May; 25(5):970-7. PubMed ID: 20546452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukopenia and thrombocytopenia in hemodialysis patients with hepatitis B or C virus infection and non-hemodialysis patients with hepatitis cirrhosis.
    Ng YY; Lin CC; Wu SC; Hwang SJ; Ho CH; Yang WC; Lee SD
    Clin Nephrol; 2002 Apr; 57(4):289-95. PubMed ID: 12005245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.
    Adinolfi LE; Utili R; Andreana A; Tripodi MF; Marracino M; Gambardella M; Giordano M; Ruggiero G
    Dig Dis Sci; 2001 Aug; 46(8):1677-83. PubMed ID: 11508667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and histological characteristics of HIV and hepatitis C virus-co-infected patients in Brazil: a case series study.
    Mendes-Correa MC; Widman A; Brussi ML; Guastini CF; Cavalheiro Nde P; Melo CE; Barone AA; Gianini RJ
    Rev Inst Med Trop Sao Paulo; 2008; 50(4):213-7. PubMed ID: 18813760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase.
    Hui CK; Belaye T; Montegrande K; Wright TL
    J Hepatol; 2003 Apr; 38(4):511-7. PubMed ID: 12663245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
    Stránský J; Ryzlová M; Striteský J; Horák J
    Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does end-stage kidney failure influence hepatitis C progression in hemodialysis patients?
    Luzar B; Ferlan-Marolt V; Brinovec V; Lesnicar G; Klopcic U; Poljak M
    Hepatogastroenterology; 2003; 50(49):157-60. PubMed ID: 12630013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.